Literature DB >> 23975854

News and views: at long last, an animal model of Graves' orbitopathy.

Rebecca S Bahn.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23975854      PMCID： PMC3749473          DOI： 10.1210/en.2013-1705

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  19 in total

Review 1.  Animal models of Graves' disease.

Authors:  M Ludgate
Journal:  Eur J Endocrinol       Date:  2000-01       Impact factor: 6.664

2.  Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.

Authors:  D H Khoo; P H Eng; S C Ho; E S Tai; N G Morgenthaler; L L Seah; K S Fong; S P Chee; C T Choo; S E Aw
Journal:  Thyroid       Date:  2000-12       Impact factor: 6.568

3.  Development of an animal model of autoimmune thyroid eye disease.

Authors:  M C Many; S Costagliola; M Detrait; F Denef; G Vassart; M C Ludgate
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

4.  Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease.

Authors:  Anja K Eckstein; Marco Plicht; Hildegard Lax; Markus Neuhäuser; Klaus Mann; Sebastian Lederbogen; Christian Heckmann; Joachim Esser; Nils G Morgenthaler
Journal:  J Clin Endocrinol Metab       Date:  2006-07-11       Impact factor: 5.958

5.  Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.

Authors:  Sajad Moshkelgosha; Po-Wah So; Neil Deasy; Salvador Diaz-Cano; J Paul Banga
Journal:  Endocrinology       Date:  2013-07-30       Impact factor: 4.736

Review 6.  Insight into Graves' hyperthyroidism from animal models.

Authors:  Sandra M McLachlan; Yuji Nagayama; Basil Rapoport
Journal:  Endocr Rev       Date:  2005-04-12       Impact factor: 19.871

7.  Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

Authors:  Gregorio D Chazenbalk; Pavel Pichurin; Chun-Rong Chen; Francesco Latrofa; Alan P Johnstone; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.

Authors:  Jane Pritchard; Rui Han; Noah Horst; William W Cruikshank; Terry J Smith
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.

Authors:  Glynn Baker; Gherardo Mazziotti; Chris von Ruhland; Marian Ludgate
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736
View more
  2 in total

1.  Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.

Authors:  A Schlüter; M Horstmann; S Diaz-Cano; S Plöhn; K Stähr; S Mattheis; M Oeverhaus; S Lang; U Flögel; U Berchner-Pfannschmidt; A Eckstein; J P Banga
Journal:  Clin Exp Immunol       Date:  2017-11-17       Impact factor: 4.330

2.  Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.

Authors:  Nan Xia; Xiaozhen Ye; Xiaohao Hu; Shiyu Song; Hui Xu; Mengyuan Niu; Hongwei Wang; Jian Wang
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.